Birmingham Business Journal reported on Birmingham’s latest breakthrough biotechnology company, Circulogene Theranostics and their recent surge of local investment. The article includes interviews with Mike Mullen, CEO and President, Dr. Chen Hsiung-Yeh, Chief Scientific Officer, and Dr. James Posey, associate professor of hematology and oncology at the University of Alabama at Birmingham.

Click here to view the full article.